OMNICEF® for oral suspension 250 mg/5mL

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

CompletedNCT00835549

Teva Pharmaceuticals USAHealthy

Start: 2005-03-31End: 2005-03-31Updated: 2024-08-20

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

CompletedNCT00834574

Teva Pharmaceuticals USAHealthy

Start: 2005-02-28End: 2005-03-31Updated: 2024-08-20